Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10495)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2016 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li H, Jiang JD, Peng ZG. MicroRNA-mediated interactions between host and hepatitis C virus. World J Gastroenterol 2016; 22(4): 1487-1496 [PMID: 26819516 DOI: 10.3748/wjg.v22.i4.1487] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i4/1487.htm |
| Number | Citing Articles |
| 1 |
Asahiro Morishita, Hirohito Yoneyama, Hisakazu Iwama, Koji Fujita, Miwako Watanabe, Kayo Hirose, Tomoko Tadokoro, Kyoko Oura, Teppei Sakamoto, Shima Mimura, Takako Nomura, Makoto Oryu, Takashi Himoto, Kunitada Shimotohno, Tsutomu Masaki. Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir. Oncotarget 2018; 9(62): 32054 doi: 10.18632/oncotarget.25889
|
| 2 |
Xi-Feng Fu, Hai-Chao Zhao, Chuan-Li Yang, Chang-Zhou Chen, Kang Wang, Fei Gao, Yang-Zhang Tian, Hao-Liang Zhao. MicroRNA‑203‑3p inhibits the proliferation, invasion and migration of pancreatic cancer cells by downregulating fibroblast growth factor 2. Oncology Letters 2021; 22(2) doi: 10.3892/ol.2021.12887
|
| 3 |
Anais N. Bauer, Niska Majumdar, Frank Williams, Smit Rajput, Lok R. Pokhrel, Paul P. Cook, Shaw M. Akula. MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens. Biology 2023; 12(10): 1334 doi: 10.3390/biology12101334
|
| 4 |
Xiao-Qin Lv, Li-Li Zou, Jia-Li Tan, Hu Li, Jian-Rui Li, Nan-Nan Liu, Biao Dong, Dan-Qing Song, Zong-Gen Peng. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process. European Journal of Pharmacology 2020; 883: 173323 doi: 10.1016/j.ejphar.2020.173323
|
| 5 |
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
|
| 6 |
Ana Rita Ferreira, Bruno Ramos, Alexandre Nunes, Daniela Ribeiro. Hepatitis C Virus: Evading the Intracellular Innate Immunity. Journal of Clinical Medicine 2020; 9(3): 790 doi: 10.3390/jcm9030790
|
| 7 |
Yung-Ju Yeh, Ching-Ping Tseng, Sheng-Da Hsu, His-Yuan Huang, Michael M. C. Lai, Hsien-Da Huang, Ju-Chien Cheng, J. -H. James Ou. Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection. Journal of Virology 2021; 95(4) doi: 10.1128/JVI.01800-20
|
| 8 |
Tiago Falcon, Martiela Freitas, Ana Carolina Mello, Laura Coutinho, Mario R. Alvares-da-Silva, Ursula Matte. Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/2864120
|
| 9 |
Simona Iacob, Diana Gabriela Iacob. Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01676
|
| 10 |
Jing‐hui Tian, Wen‐dong Liu, Zhi‐yong Zhang, Li‐hua Tang, Dong Li, Zhao‐ju Tian, Shao‐wei Lin, Ying‐jie Li. Influence of miR‐520e‐mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. Journal of Viral Hepatitis 2019; 26(4): 496 doi: 10.1111/jvh.13048
|
| 11 |
Hyo-Jung Park, Hae Li Ko, Seo-Yeon Jung, Han-Byeol Jo, Jae-Hwan Nam. The Characteristics of RNA Vaccine; its Strengths and Weaknesses. Journal of Bacteriology and Virology 2016; 46(3): 115 doi: 10.4167/jbv.2016.46.3.115
|
| 12 |
Adit Singhal, Aniruddh Agrawal, Jun Ling. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs. Journal of Cellular and Molecular Medicine 2018; 22(4): 2071 doi: 10.1111/jcmm.13553
|
| 13 |
|
| 14 |
Katharina Herzog, Simonetta Bandiera, Sophie Pernot, Catherine Fauvelle, Frank Jühling, Amélie Weiss, Anne Bull, Sarah C Durand, Béatrice Chane-Woon-Ming, Sébastien Pfeffer, Marion Mercey, Hervé Lerat, Jean-Christophe Meunier, Wolfgang Raffelsberger, Laurent Brino, Thomas F Baumert, Mirjam B Zeisel. Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity. Gut 2020; 69(2): 380 doi: 10.1136/gutjnl-2018-317423
|
| 15 |
Wei Chen, Jinwei Li, Jing Li, Jiayu Zhang, Jihong Zhang. Roles of Non-Coding RNAs in Virus-Host Interaction About Pathogenesis of Hand-Foot-Mouth Disease. Current Microbiology 2022; 79(9) doi: 10.1007/s00284-022-02928-z
|
| 16 |
Maryam Shafaati, Mohammadreza Salehi, Maryam Zare. Liver Cancer - Multidisciplinary Approach. 2024; doi: 10.5772/intechopen.1005068
|
| 17 |
Zekiye Cemre Demir, Aliye Bastug, Hurrem Bodur, Koray Ergunay, Aykut Ozkul. MicroRNA expression profiles in patients with acute Crimean Congo hemorrhagic fever reveal possible adjustments to cellular pathways. Journal of Medical Virology 2017; 89(3): 417 doi: 10.1002/jmv.24667
|
| 18 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Konstantinos Papanikolopoulos, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Dimitris Matthaios, Michalis V. Karamouzis. An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches. International Journal of Molecular Sciences 2023; 24(8): 7168 doi: 10.3390/ijms24087168
|
| 19 |
MeiXia Sui, ZongWei Wang, Dan Xi, HanHai Wang. miR‐142‐5P regulates triglyceride by targeting CTNNB1 in goat mammary epithelial cells. Reproduction in Domestic Animals 2020; 55(5): 613 doi: 10.1111/rda.13660
|
| 20 |
Christopher Isaac, Trushar R. Patel, Athanasios Zovoilis. Non-coding RNAs in virology: an RNA genomics approach. Biotechnology and Genetic Engineering Reviews 2018; 34(1): 90 doi: 10.1080/02648725.2018.1471642
|
| 21 |
Yajie Hu, Jie Song, Longding Liu, Jing Li, Beibei Tang, Jingjing Wang, Xiaolong Zhang, Ying Zhang, Lichun Wang, Yun Liao, Zhanlong He, Qihan Li. Different microRNA alterations contribute to diverse outcomes following EV71 and CA16 infections: Insights from high-throughput sequencing in rhesus monkey peripheral blood mononuclear cells. The International Journal of Biochemistry & Cell Biology 2016; 81: 20 doi: 10.1016/j.biocel.2016.10.011
|
| 22 |
Lingyao Du, Hong Tang. miRNA Antagonism and direct-acting Antivirals: Could This Be a Novel Combination Treatment Against HCV?. Future Virology 2016; 11(12): 753 doi: 10.2217/fvl-2016-0109
|
| 23 |
Javid Sadri Nahand, Farah Bokharaei‐Salim, Arash Salmaninejad, Abolfazl Nesaei, Fatemeh Mohajeri, Azadeh Moshtzan, Alireza Tabibzadeh, Mohammad Karimzadeh, Mohsen Moghoofei, Arezo Marjani, Shoeleh Yaghoubi, Hossein Keyvani. microRNAs: Key players in virus‐associated hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(8): 12188 doi: 10.1002/jcp.27956
|
| 24 |
Óscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, Javier Crespo García, Pablo Ryan Murúa, Juan Macías, Joaquín Cabezas González, Jesús Troya, Juan Antonio Pineda, María Teresa Arias Loste, Victorino Díez Viñas, María Ángeles Jiménez-Sousa, Luz María Medrano de Dios, Isabel Cuesta De la Plaza, Sara Monzón Fernández, Salvador Resino García, Amanda Fernández-Rodríguez. MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection. Journal of Clinical Medicine 2019; 8(6): 849 doi: 10.3390/jcm8060849
|
| 25 |
Xijing Qian, Chen Xu, Shuo Fang, Ping Zhao, Yue Wang, Houqi Liu, Wen Yuan, Zhongtian Qi. Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection. Stem Cells Translational Medicine 2016; 5(9): 1190 doi: 10.5966/sctm.2015-0348
|
| 26 |
Mousumi Khatun, Ratna B. Ray. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells 2019; 8(10): 1249 doi: 10.3390/cells8101249
|
| 27 |
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis. Viruses 2022; 14(8): 1776 doi: 10.3390/v14081776
|
| 28 |
Nearmeen M. Rashad, Amal S. El-Shal, Sally M. Shalaby, Salem Y. Mohamed. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 447(1-2): 125 doi: 10.1007/s11010-018-3298-8
|
| 29 |
Suchandrima Ghosh, Joyeeta Chakraborty, Avijit Goswami, Sayantani Bhowmik, Susree Roy, Amit Ghosh, Sakshi Dokania, Priyanka Kumari, Simanti Datta, Abhijit Chowdhury, Suvendra Nath Bhattacharyya, Raghunath Chatterjee, Soma Banerjee. A novel microRNA boosts hyper-β-oxidation of fatty acids in liver by impeding CEP350-mediated sequestration of PPARα and thus restricts chronic hepatitis C. RNA Biology 2020; 17(9): 1352 doi: 10.1080/15476286.2020.1768353
|
| 30 |
Murali Ganesan, Sathish Kumar Natarajan, Jinjin Zhang, Justin L. Mott, Larisa I. Poluektova, Benita L. McVicker, Kusum K. Kharbanda, Dean J. Tuma, Natalia A. Osna. Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(11): G930 doi: 10.1152/ajpgi.00021.2016
|
| 31 |
Xijing Qian, Bingan Wu, Chen Xu, Zhongtian Qi. Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific miR-4423-3p Targets RIG-I to Facilitate Infection. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.851917
|
| 32 |
Iqra Almas, Samia Afzal, Muhammad Idrees, Muhammad Usman Ashraf, Iram Amin, Muhammad Shahid, Khadija Zahid, Sadia Zahid. Role of circulatory microRNAs in the pathogenesis of hepatitis C virus. VirusDisease 2017; 28(4): 360 doi: 10.1007/s13337-017-0407-3
|
| 33 |
Li-Pei Wu, Jian Wu, Anquan Shang, Man Yang, Ling-Ling Li, Jing Yu, Lei-Rong Xu, Chun-Bing Wang, Wei-Wei Wang, Jian-Jun Zhu, Wen-Ying Lu. miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46(sup1): 159 doi: 10.1080/21691401.2017.1415918
|
| 34 |
Mahmoud Kandeel. Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies. Pharmaceuticals 2023; 16(4): 485 doi: 10.3390/ph16040485
|
| 35 |
Chiara Siniscalchi, Armando Di Palo, Aniello Russo, Nicoletta Potenza. Human MicroRNAs Interacting With SARS-CoV-2 RNA Sequences: Computational Analysis and Experimental Target Validation. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.678994
|
| 36 |
Michela Bulfoni, Riccardo Pravisani, Emiliano Dalla, Daniela Cesselli, Masaaki Hidaka, Carla Di Loreto, Susumu Eguchi, Umberto Baccarani. miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation. Journal of Medical Virology 2021; 93(8): 4992 doi: 10.1002/jmv.26999
|
| 37 |
Amanda Abdel-Al, Eman El-Ahwany, Mona Zoheiry, Marwa Hassan, Amged Ouf, Hoda Abu-Taleb, Ali Abdel Rahim, Mohamed Darwish El-Talkawy, Suher Zada. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Research 2018; 253: 135 doi: 10.1016/j.virusres.2018.06.007
|
| 38 |
Chao Liu, Xueyun Hou, Kaixin Mo, Nannan Li, Cheng An, Guijian Liu, Zongdai Pan. Serum non‐coding RNAs for diagnosis and stage of liver fibrosis. Journal of Clinical Laboratory Analysis 2022; 36(10) doi: 10.1002/jcla.24658
|